Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 87027

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
December 22, 2020
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Strides Pharma Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816

D-0180-2021
Recall number
D-0180-2021
Initiated
December 22, 2020
Classification
Class III
Status
Terminated
Recalling firm
Strides Pharma Inc.
Quantity
960 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Failed Moisture Limits

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Moisture Limits

Code information

Lot 7242728A; June 2023

Distribution pattern

PA